Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
Abizaid, Alexandre
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Oct 2013 - 721-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1969-6213
10.4244/EIJV9I6A116 doi
Angioplasty, Balloon, Coronary
Coronary Angiography
Coronary Artery Disease
Drug-Eluting Stents
Follow-Up Studies
Humans
Paclitaxel
Prospective Studies
Sirolimus
Stents
Taxus
Treatment Outcome
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Oct 2013 - 721-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1969-6213
10.4244/EIJV9I6A116 doi
Angioplasty, Balloon, Coronary
Coronary Angiography
Coronary Artery Disease
Drug-Eluting Stents
Follow-Up Studies
Humans
Paclitaxel
Prospective Studies
Sirolimus
Stents
Taxus
Treatment Outcome